WO2010123041A1 - Catheter and medication administering device - Google Patents

Catheter and medication administering device Download PDF

Info

Publication number
WO2010123041A1
WO2010123041A1 PCT/JP2010/057099 JP2010057099W WO2010123041A1 WO 2010123041 A1 WO2010123041 A1 WO 2010123041A1 JP 2010057099 W JP2010057099 W JP 2010057099W WO 2010123041 A1 WO2010123041 A1 WO 2010123041A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug
catheter
holes
internal channel
inlet
Prior art date
Application number
PCT/JP2010/057099
Other languages
French (fr)
Japanese (ja)
Inventor
剛 外川
広明 小関
香由 木村
正伸 清原
博英 深澤
Original Assignee
オリンパス株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オリンパス株式会社 filed Critical オリンパス株式会社
Publication of WO2010123041A1 publication Critical patent/WO2010123041A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407Infusion of two or more substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body

Definitions

  • the present invention relates to a catheter which is inserted into a living body and which discharges a drug from a plurality of through holes provided on the side, and a drug administration device using the catheter.
  • a catheter inserted into a human or a mammal other than a human or the like has an elongated tubular shape having a channel inside.
  • a portion of the tubular casing inserted into the body is provided with a through hole communicating the internal channel with the outside for the purpose of discharging the medicine and the like.
  • Some such catheters are provided with a plurality of through holes on the side surface so that the medicine can be discharged to a wide area from the plurality of through holes on the side surface.
  • the drug is delivered from a drug delivery source such as a pump, taken from the proximal side of the catheter toward the internal channel, and discharged into the body from the plurality of through holes (for example, , Patent Document 1).
  • a drug delivery source such as a pump
  • the discharge amount of the drug is not the same in the through hole close to the proximal end and the through hole close to the distal end. That is, even if a sufficient discharge amount can be obtained by the through hole close to the proximal end, a state in which the drug is sequentially discharged by the through hole in the middle and the pressure of the drug in the internal channel decreases. As a result, in many cases, a sufficient discharge amount can not be obtained in the through hole near the distal end, and there has been a phenomenon that the discharge amount gradually decreases as the position of the through hole goes from the proximal end to the distal end.
  • This invention is made in view of the above, Comprising: It aims at providing the catheter and drug administration device which can extend the administration range of medicine etc. by simple composition.
  • the catheter according to the present invention is an elongated tubular casing having an inner channel, and a first drug intake for introducing a drug into the inner channel; A second drug inlet for introducing drug into the inner channel, and a side of the tubular housing, located between the first drug inlet and the second drug inlet, the inner channel and the outer And a plurality of through holes communicating with each other.
  • the catheter according to the present invention is characterized in that it has a bent portion bent in a U-shape in the middle of the elongated tubular housing.
  • the catheter according to the present invention further includes a branching device for branching one flow path from the drug delivery source toward the first drug intake and the second drug intake. It is characterized by having.
  • the internal channel may be a first internal channel in communication with the first drug inlet, and a second internal in communication with the second drug inlet. And a plurality of second through holes connecting the first inner channel and the outside, and a plurality of second through holes connecting the second inner channel and the outside.
  • the drug administration device is an elongated tubular casing having an inner channel, and a first drug intake for introducing the drug into the inner channel and a second drug for introducing the drug into the inner channel.
  • the drug delivery source is a first drug delivery source in direct or indirect communication with a first drug intake of the catheter; And a second drug delivery source other than the first drug delivery source in direct or indirect communication with the second drug delivery port.
  • the drug administration device is characterized in that, in the above-mentioned invention, a bending portion bent in a U-shape is provided in the middle of the elongated tubular housing of the catheter.
  • the drug delivery source is a single device, and the catheter is configured to transmit one flow path from the single drug delivery source to the first device.
  • a branching device for branching to the second drug inlet and the second drug inlet.
  • the internal channel is in communication with a first internal channel in communication with the first medicine intake, and a second in communication with the second medicine intake.
  • a plurality of first through holes communicating the first internal channel with the outside, and a plurality of second through holes communicating the second internal channel with the outside And two or more through holes, wherein the first internal channel and the second internal channel are separated from each other, and a range in which the plurality of first through holes are located in the axial direction of the tubular housing It is characterized in that at least a part overlaps with the range in which the second through hole of (4) is located.
  • a drug administration device has an elongated tubular housing having an inner channel, and a catheter having a plurality of through holes communicating the inner channel with the outside on the side, and the inner channel of the catheter And at least one drug delivery source for delivering the drug to the plurality of through holes through the internal channel in opposite directions from the opposite end sides of the catheter. It is characterized by sending out.
  • an elongated tubular casing having an inner channel is provided, a first drug inlet for introducing a drug into the inner channel, a second drug inlet for introducing a drug into the inner channel, and What is claimed is: 1.
  • FIG. 1 is a schematic view showing a schematic configuration of a catheter according to Embodiment 1 of the present invention.
  • FIG. 2 is a schematic view showing a schematic configuration of a drug administration device using the catheter shown in FIG.
  • FIG. 3 is a view showing the discharge amount distribution of a plurality of through holes in the case where a drug is delivered from the first drug intake using only one pump.
  • FIG. 4 is a diagram showing the discharge amount distribution of a plurality of through holes in the case where a drug is delivered from the second drug inlet using only one pump.
  • FIG. 5 is a view showing the discharge amount distribution of a plurality of through holes when drugs are discharged from both ends of the first drug inlet and the second drug inlet by two pumps.
  • FIG. 1 is a schematic view showing a schematic configuration of a catheter according to Embodiment 1 of the present invention.
  • FIG. 2 is a schematic view showing a schematic configuration of a drug administration device using the catheter shown in FIG.
  • FIG. 3 is a view
  • FIG. 6 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to the second embodiment of the present invention.
  • FIG. 7 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to the modification of the second embodiment of the present invention.
  • FIG. 8 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to the third embodiment of the present invention.
  • FIG. 9 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to a modification of the third embodiment of the present invention.
  • FIG. 10 is a schematic view showing a schematic configuration of a catheter according to a fourth embodiment of the present invention.
  • FIG. 11 is a schematic view showing a schematic configuration of a catheter according to a fifth embodiment of the present invention.
  • FIG. 12 is a schematic view showing a schematic configuration of a catheter according to Embodiment 6 of the present invention.
  • FIG. 13 is a schematic view showing a schematic configuration of a catheter according to Modification 1 of Embodiment 6 of the present invention.
  • FIG. 14 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to the second modification of the sixth embodiment of the present invention.
  • FIG. 15 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to the third modification of the sixth embodiment of the present invention.
  • FIG. 1 is a schematic view showing a schematic configuration of a catheter according to Embodiment 1 of the present invention.
  • the catheter 1 is an elongated tubular housing 2 having an internal channel 3 and has a plurality of through holes 4 communicating the internal channel 3 with the outside on the side.
  • the entire catheter 1 is made of a biocompatible material such as polyurethane, elastic silicone, Teflon (registered trademark), polyvinyl chloride, polyethylene and the like.
  • one end of a tubular housing 2 introduces a drug into the internal channel 3 and a first drug intake port 5 which is an opening communicating with the internal channel 3 and the other end of the tubular housing 2
  • a drug is introduced into the channel 3 and has a second drug inlet 6 which is an opening communicating with the internal channel 3.
  • the plurality of through holes 4 are located between the first drug inlet 5 and the second drug inlet 6 on the side surface of the tubular housing 2.
  • FIG. 2 is a schematic view showing a schematic configuration of a drug administration device using the catheter shown in FIG. As shown in FIG. 2, the catheter 1 is inserted into the administration target 10 such as a tumor in the body via the body surface 11, and the through hole 4 is disposed in the administration target 10.
  • the administration target 10 such as a tumor in the body via the body surface 11, and the through hole 4 is disposed in the administration target 10.
  • a pump 7 as a first drug delivery source is connected to and in communication with the first drug inlet 5 of the catheter 1, and a second drug delivery source is connected to the second drug inlet 6.
  • the pump 8 is connected and in communication.
  • the pump 7 and the pump 8 are directly connected to the catheter 1 in FIG. 2 respectively, they may be connected and communicated indirectly via other members.
  • the pumps 7 and 8 are attached to the body surface 11, it may be not only this but may be embedded in the body, and may be spaced apart and provided outside the body.
  • the drug discharge amount distribution from each through hole 4 when using the catheter 1 and the pumps 7 and 8 will be described.
  • the plurality of through holes 4 are described as sequentially arranged through holes 4a, 4b, 4c, 4d of the same diameter in the axial direction from the first medicine intake 5 side. Do.
  • FIG. 3 is a diagram showing the discharge amount distribution of the through holes 4a to 4d when only the pump 7 is used.
  • the discharge amount is successively reduced in the order of the through holes 4 a ⁇ 4 b ⁇ 4 c ⁇ 4 d.
  • This is a pressure reducing effect in which the drug is sequentially discharged from the through holes as it is separated from the pump 7, and the discharge pressure is gradually reduced, and as a result, the discharge amount is reduced.
  • FIG. 4 is a view showing the discharge amount distribution of the through holes 4a to 4d when only the pump 8 is used.
  • the discharge amount is successively reduced in the order of the through holes 4 d ⁇ 4 c ⁇ 4 b ⁇ 4 a.
  • This is a pressure reducing effect in which the drug is sequentially discharged from the through holes as it is separated from the pump 8, and the discharge pressure gradually decreases, and as a result, the discharge amount decreases.
  • FIG. 5 shows the discharge amount distribution of the through holes 4a to 4d when the medicine is discharged from both ends of the first medicine intake 5 and the second medicine intake 6 by the pumps 7, 8 FIG.
  • the discharge amount distribution obtained by combining the discharge amount distributions shown in FIGS. 3 and 4 is obtained, the influence of the pressure reduction effect due to the positions of the through holes 4a to 4d is reduced, and a substantially uniform discharge amount distribution is obtained. That is, as shown in FIG. 2, the amount of discharge of each through hole 4 (4a to 4d) is made almost constant by delivering the medicine from both ends of the catheter 1 and discharging it from the plurality of through holes 4 on the side. can do.
  • the influence of the pressure reduction effect is reduced, the axial region in which the through hole 4 is provided can be widened. The effects of making the discharge amount distribution uniform and widening the discharge area are obtained when a plurality of through holes 4 are provided.
  • the tubular casing 2 is straight, but in the second embodiment, as shown in FIG. 6, the tubular casing 2 is U-shaped in the middle of the elongated tubular casing 2 of the catheter 1.
  • a bent portion 12 is provided.
  • the plurality of through holes 4 are provided on one side surface of the bending portion 12.
  • a through hole 4 ′ may be further provided on the other side surface of the bending portion 12 so that the medicine can be discharged from both sides of the side surface of the bending portion 12.
  • branching devices 13 are further provided at both ends of the catheter of the second embodiment having the bending portion 12.
  • the branching device 13 branches one flow path 14 from the drug delivery source toward the first drug inlet 5 and the second drug inlet 6. This makes it possible to use one pump as a drug delivery source.
  • the branching unit 13 may further have a flow rate adjustment function or the like.
  • through holes may be further provided in the other side surface of the bending portion 12 so that the medicine can be discharged from both sides of the side surface of the bending portion 12 (see FIG. 9).
  • the catheter has the bending portion 12.
  • the catheter having no bending portion 12 shown in FIG. 10 the catheter having no bending portion 12 shown in FIG.
  • a branching device 13a is provided, which connects both ends of one, that is, the first drug inlet 5 and the second drug inlet 6, and also connects the flow path 14 to which one pump is connected. That is, the branch portion 13 a branches the medicine flowing in through the flow path 14 and delivers the medicine from the first medicine intake 5 and the second medicine intake 6 toward the through hole 4. .
  • the same function and effect as the first embodiment can be obtained with a simple configuration in which only one pump is used.
  • the casing 2 of the catheter 1 can be inserted into the medicine ejection portion 20 where the plurality of through holes 4 are located and the medicine ejection portion 20, and the through holes
  • the two non-conduit portions 21 and 22 are separately configured.
  • the positions of the conduits 21 and 22 with respect to the medicine ejection unit 20 can be adjusted in the axial direction. That is, after the conduits 21 and 22 are moved to appropriate positions with respect to the medicine ejection unit 20, the desired catheter is obtained by fixing the position with an adhesive or the like.
  • the medicine is discharged only from the through hole 31 not covered by the conduits 21 and 22 among the plurality of through holes 4, and the medicine from the through holes 30 covered by the conduits 21 and 22 is medicine Is not discharged. Therefore, by appropriately adjusting the positions of the conduits 21 and 22 with respect to the medicine ejection unit 20, it is possible to limit the through holes to be used depending on the situation. Thereby, according to the conditions, such as the magnitude
  • FIG. 12 a first internal channel 43a in which the internal channel 43 corresponding to the internal channel 3 communicates with the first medicine intake 45, and a second medicine And a second internal channel 43 b in communication with the inlet 46.
  • the plurality of through holes are a plurality of first through holes 44 communicating the first inner channel 43 a with the outside, and a plurality of second through holes 48 communicating the second inner channel 43 b with the outside. It is divided. That is, the drug that has passed through the first inner channel 43 a is discharged from the plurality of first through holes 44, and the drug that has passed through the second inner channel 43 b is discharged from the plurality of second through holes 48. That is, there are two combinations of the internal channels 43a and 43b and the through holes 44 and 48, respectively.
  • the discharge amount distribution from the first through hole 44 has a profile as shown in FIG. 3
  • the discharge amount distribution from the second through hole 48 has a profile as shown in FIG. Since, in this overlapping range, the sum of the discharge amounts of the first through holes 44 and the second through holes 48 contributes, the discharge amount distribution as a whole becomes a profile as shown in FIG. It becomes almost uniform at the through hole position.
  • This modification 1 applies the configuration of the sixth embodiment to the second embodiment, and has a bending portion 52 corresponding to the bending portion 12 as shown in FIG.
  • the bent portion 52 is coupled by the coupling member 51.
  • insertion of the catheter 41 into the administration target 10 can be performed from one direction. The procedure can be simplified.
  • This modification 2 is obtained by applying the configuration of the sixth embodiment to the third embodiment, and as shown in FIG. 14, it branches further to both ends of the catheter of the modification 1 having the bending portion 52.
  • the vessel 13 is provided.
  • the branching device 13 branches one flow path 14 from the drug delivery source toward the first drug inlet 45 and the second drug inlet 46. This makes it possible to use one pump as a drug delivery source.

Abstract

A medication administering device comprising: a catheter (1) which is formed as an elongated tubular body (2) having an inner channel, the catheter (1) being provided with a first medication inlet (5) which introduces a medication into the inner channel, a second medication inlet (6) which introduces a medication into the inner channel, and through-holes (4) which are formed in the side surface of the tubular body (2) at positions between the first medication inlet (5) and the second medication inlet (6) and connect the inner channel and the outside; a pump (7) which communicates with the first medication inlet (5) of the catheter (1) and discharges the medication to the through-hole (4) side; and a pump (8) which communicates with the second medication inlet (6) of the catheter (1) and discharges the medication to the through-hole (4) side.

Description

カテーテルおよび薬剤投与装置Catheter and drug administration device
 この発明は、生体内に挿入され、側面に配設された複数の貫通穴から薬剤を吐出するカテーテルおよびこのカテーテルを用いた薬剤投与装置に関するものである。 The present invention relates to a catheter which is inserted into a living body and which discharges a drug from a plurality of through holes provided on the side, and a drug administration device using the catheter.
 従来から、人間や人間以外の哺乳動物等に挿入されるカテーテルは、内部にチャネルを有する細長い管状をしている。この管状の躯体のうち体内に挿入される部分には、薬剤の吐出等を目的として内部チャネルと外部とを連通する貫通穴が設けられている。このようなカテーテルには、側面に複数の貫通穴を設け、この側面の複数の貫通穴から広い領域に薬剤を吐出できるようにしたものがある。この側面に複数の貫通穴を有するカテーテルでは、薬剤をポンプ等の薬剤送出源から送出し、カテーテルの基端側から内部チャネルに向けて取り入れ、複数の貫通穴から体内に吐出していた(たとえば、特許文献1参照)。 Conventionally, a catheter inserted into a human or a mammal other than a human or the like has an elongated tubular shape having a channel inside. A portion of the tubular casing inserted into the body is provided with a through hole communicating the internal channel with the outside for the purpose of discharging the medicine and the like. Some such catheters are provided with a plurality of through holes on the side surface so that the medicine can be discharged to a wide area from the plurality of through holes on the side surface. In a catheter having a plurality of through holes on this side, the drug is delivered from a drug delivery source such as a pump, taken from the proximal side of the catheter toward the internal channel, and discharged into the body from the plurality of through holes (for example, , Patent Document 1).
特表2003-504132号公報Japanese Patent Publication No. 2003-504132
 しかしながら、従来のカテーテルで、基端から一方向に薬剤を投入する場合、基端に近い貫通穴と先端に近い貫通穴とでは、薬剤の吐出量が同一ではなかった。すなわち、基端に近い貫通穴で十分な吐出量が得られても、途中の貫通穴で薬剤が順次吐出されて内部チャネル内の薬剤の圧力が低下する状態が生じる。この結果、先端近くの貫通穴では十分な吐出量が得られない場合が多く、貫通穴の位置が基端から先端になるにつれ、吐出量が漸減する現象があった。 However, in the case of injecting a drug in one direction from the proximal end in the conventional catheter, the discharge amount of the drug is not the same in the through hole close to the proximal end and the through hole close to the distal end. That is, even if a sufficient discharge amount can be obtained by the through hole close to the proximal end, a state in which the drug is sequentially discharged by the through hole in the middle and the pressure of the drug in the internal channel decreases. As a result, in many cases, a sufficient discharge amount can not be obtained in the through hole near the distal end, and there has been a phenomenon that the discharge amount gradually decreases as the position of the through hole goes from the proximal end to the distal end.
 このような吐出量が漸減する現象は、カテーテルの側面に複数の貫通穴を設ける領域の長さに限界をもたらしていた。すなわち、従来のカテーテルでは、1本のカテーテルで薬剤を投与できる範囲が小さく限られるという問題点があった。 Such a phenomenon in which the amount of discharge gradually decreases brings about a limit to the length of the region where a plurality of through holes are provided on the side of the catheter. That is, in the conventional catheter, there is a problem that the range in which the drug can be administered by one catheter is limited.
 この発明は、上記に鑑みてなされたものであって、簡易な構成で、薬剤等の投与範囲を広くすることができるカテーテルおよび薬剤投与装置を提供することを目的とする。 This invention is made in view of the above, Comprising: It aims at providing the catheter and drug administration device which can extend the administration range of medicine etc. by simple composition.
 上述した課題を解決し、目的を達成するために、この発明にかかるカテーテルは、内部チャネルを有する細長い管状の躯体をしており、前記内部チャネルに薬剤を取り入れる第1の薬剤取入口と、前記内部チャネルに薬剤を取り入れる第2の薬剤取入口と、前記管状の躯体の側面であって前記第1の薬剤取入口と前記第2の薬剤取入口との間に位置し、前記内部チャネルと外部とを連通する複数の貫通穴と、を有することを特徴とする。 In order to solve the problems described above and to achieve the object, the catheter according to the present invention is an elongated tubular casing having an inner channel, and a first drug intake for introducing a drug into the inner channel; A second drug inlet for introducing drug into the inner channel, and a side of the tubular housing, located between the first drug inlet and the second drug inlet, the inner channel and the outer And a plurality of through holes communicating with each other.
 また、この発明にかかるカテーテルは、上記の発明において、前記細長い管状の躯体の途中に、U字型に折り曲がった屈曲部を有することを特徴とする。 In the above-mentioned invention, the catheter according to the present invention is characterized in that it has a bent portion bent in a U-shape in the middle of the elongated tubular housing.
 また、この発明にかかるカテーテルは、上記の発明において、薬剤の送出源からの一つの流路を前記第1の薬剤取入口と前記第2の薬剤取入口とに向けて分岐させる分岐器をさらに有することを特徴とする。 Further, in the above-mentioned invention, the catheter according to the present invention further includes a branching device for branching one flow path from the drug delivery source toward the first drug intake and the second drug intake. It is characterized by having.
 また、この発明にかかるカテーテルは、上記の発明において、前記内部チャネルは、前記第1の薬剤取入口に連通する第1の内部チャネルと、前記第2の薬剤取入口に連通する第2の内部チャネルとを含み、前記複数の貫通穴は、前記第1の内部チャネルと外部とを連通する複数の第1の貫通穴と、前記第2の内部チャネルと外部とを連通する複数の第2の貫通穴を含み、前記第1の内部チャネルと前記第2の内部チャネルとは互いに分離され、前記管状の躯体の軸方向において前記複数の第1の貫通穴が位置する範囲と前記複数の第2の貫通穴が位置する範囲とは少なくとも一部が重複することを特徴とする。 In the catheter according to the present invention, in the above-mentioned invention, the internal channel may be a first internal channel in communication with the first drug inlet, and a second internal in communication with the second drug inlet. And a plurality of second through holes connecting the first inner channel and the outside, and a plurality of second through holes connecting the second inner channel and the outside. A range in which the plurality of first through holes are located in the axial direction of the tubular housing and the plurality of second through holes, the through holes being included, the first internal channel and the second internal channel being separated from each other It is characterized in that at least a part overlaps with the range in which the through hole of the above is located.
 また、この発明にかかる薬剤投与装置は、内部チャネルを有する細長い管状の躯体をしており、前記内部チャネルに薬剤を取り入れる第1の薬剤取入口と、前記内部チャネルに薬剤を取り入れる第2の薬剤取入口と、前記管状の躯体の側面であって前記第1の薬剤取入口と前記第2の薬剤取入口との間に位置し前記内部チャネルと外部とを連通する複数の貫通穴と、を有するカテーテルと、前記カテーテルの第1の薬剤取入口と第2の薬剤取入口とに、直接または間接に連通する少なくとも一つの薬剤送出源と、を有することを特徴とする。 Further, the drug administration device according to the present invention is an elongated tubular casing having an inner channel, and a first drug intake for introducing the drug into the inner channel and a second drug for introducing the drug into the inner channel. An inlet, and a plurality of through holes located between the first drug inlet and the second drug inlet, which are side surfaces of the tubular housing, and which communicate the inner channel with the outside; A catheter having at least one drug delivery source in direct or indirect communication with the first drug inlet and the second drug inlet of the catheter.
 また、この発明にかかる薬剤投与装置は、上記の発明において、前記薬剤送出源は、前記カテーテルの第1の薬剤取入口に直接または間接に連通する第1の薬剤送出源と、前記カテーテルの第2の薬剤取入口に直接または間接に連通する前記第1の薬剤送出源とは別の第2の薬剤送出源とを含むことを特徴とする。 Further, in the drug administration device according to the present invention, in the above-mentioned invention, the drug delivery source is a first drug delivery source in direct or indirect communication with a first drug intake of the catheter; And a second drug delivery source other than the first drug delivery source in direct or indirect communication with the second drug delivery port.
 また、この発明にかかる薬剤投与装置は、上記の発明において、前記カテーテルの細長い管状の躯体の途中に、U字型に折り曲がった屈曲部を有することを特徴とする。 Further, the drug administration device according to the present invention is characterized in that, in the above-mentioned invention, a bending portion bent in a U-shape is provided in the middle of the elongated tubular housing of the catheter.
 また、この発明にかかる薬剤投与装置は、上記の発明において、前記薬剤送出源は、単一の装置であり、前記カテーテルは、前記単一の薬剤送出源からの一つの流路を前記第1の薬剤取入口と前記第2の薬剤取入口とに向けて分岐させる分岐器をさらに有することを特徴とする。 Further, in the drug administration device according to the present invention according to the above-mentioned invention, the drug delivery source is a single device, and the catheter is configured to transmit one flow path from the single drug delivery source to the first device. And a branching device for branching to the second drug inlet and the second drug inlet.
 また、この発明にかかる薬剤投与装置は、上記の発明において、前記内部チャネルは、前記第1の薬剤取入口に連通する第1の内部チャネルと、前記第2の薬剤取入口に連通する第2の内部チャネルとを含み、前記複数の貫通穴は、前記第1の内部チャネルと外部とを連通する複数の第1の貫通穴と、前記第2の内部チャネルと外部とを連通する複数の第2の貫通穴とを含み、前記第1の内部チャネルと前記第2の内部チャネルとは互いに分離され、前記管状の躯体の軸方向において前記複数の第1の貫通穴が位置する範囲と前記複数の第2の貫通穴が位置する範囲とは少なくとも一部が重複することを特徴とする。 In the medicine administration device according to the present invention, in the above-mentioned invention, the internal channel is in communication with a first internal channel in communication with the first medicine intake, and a second in communication with the second medicine intake. A plurality of first through holes communicating the first internal channel with the outside, and a plurality of second through holes communicating the second internal channel with the outside And two or more through holes, wherein the first internal channel and the second internal channel are separated from each other, and a range in which the plurality of first through holes are located in the axial direction of the tubular housing It is characterized in that at least a part overlaps with the range in which the second through hole of (4) is located.
 また、この発明にかかる薬剤投与装置は、内部チャネルを有する細長い管状の躯体をしており、側面に前記内部チャネルと外部とを連通する複数の貫通穴をもつカテーテルと、前記カテーテルの前記内部チャネルに薬剤を送出する少なくとも一つの薬剤送出源と、を有し、前記薬剤送出源は、前記カテーテルの両端側から各々逆方向に、前記内部チャネルを通って前記複数の貫通穴に向けて薬剤を送出することを特徴とする。 Further, a drug administration device according to the present invention has an elongated tubular housing having an inner channel, and a catheter having a plurality of through holes communicating the inner channel with the outside on the side, and the inner channel of the catheter And at least one drug delivery source for delivering the drug to the plurality of through holes through the internal channel in opposite directions from the opposite end sides of the catheter. It is characterized by sending out.
 この発明によれば、内部チャネルを有する細長い管状の躯体をしており、前記内部チャネルに薬剤を取り入れる第1の薬剤取入口と、前記内部チャネルに薬剤を取り入れる第2の薬剤取入口と、前記管状の躯体の側面であって前記第1の薬剤取入口と前記第2の薬剤取入口との間に位置し、前記内部チャネルと外部とを連通する複数の貫通穴と、を有したカテーテルの前記第1の薬剤取入口と前記第2の薬剤取入口とからそれぞれ逆方向に前記複数の貫通穴に向けて薬剤を吐出し、該複数の貫通穴における薬剤の吐出を可能にしているので、簡易な構成で、薬剤等の投与範囲を広くすることができる。 According to the invention, an elongated tubular casing having an inner channel is provided, a first drug inlet for introducing a drug into the inner channel, a second drug inlet for introducing a drug into the inner channel, and What is claimed is: 1. A catheter having a plurality of through holes located between the first drug inlet and the second drug inlet on the side surface of the tubular housing and communicating the internal channel with the outside. Since the medicine is discharged from the first medicine intake and the second medicine intake in the opposite direction to the plurality of through holes, and the medicine can be discharged from the plurality of through holes, The administration range of drugs etc. can be broadened by a simple configuration.
図1は、この発明の実施の形態1にかかるカテーテルの概要構成を示す模式図である。FIG. 1 is a schematic view showing a schematic configuration of a catheter according to Embodiment 1 of the present invention. 図2は、図1に示したカテーテルを用いた薬剤投与装置の概要構成を示す模式図である。FIG. 2 is a schematic view showing a schematic configuration of a drug administration device using the catheter shown in FIG. 図3は、第1の薬剤取入口から一つのポンプのみを用いて薬剤を送出した場合における複数の貫通穴の吐出量分布を示す図である。FIG. 3 is a view showing the discharge amount distribution of a plurality of through holes in the case where a drug is delivered from the first drug intake using only one pump. 図4は、第2の薬剤取込口から一つのポンプのみを用いて薬剤を送出した場合における複数の貫通穴の吐出量分布を示す図である。FIG. 4 is a diagram showing the discharge amount distribution of a plurality of through holes in the case where a drug is delivered from the second drug inlet using only one pump. 図5は、二つのポンプによって第1の薬剤取入口および第2の薬剤取入口の両端側から薬剤を吐出した場合の複数の貫通穴の吐出量分布を示した図である。FIG. 5 is a view showing the discharge amount distribution of a plurality of through holes when drugs are discharged from both ends of the first drug inlet and the second drug inlet by two pumps. 図6は、この発明の実施の形態2にかかるカテーテルの貫通穴近傍の構成を示す模式図である。FIG. 6 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to the second embodiment of the present invention. 図7は、この発明の実施の形態2の変形例にかかるカテーテルの貫通穴近傍の構成を示す模式図である。FIG. 7 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to the modification of the second embodiment of the present invention. 図8は、この発明の実施の形態3にかかるカテーテルの貫通穴近傍の構成を示す模式図である。FIG. 8 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to the third embodiment of the present invention. 図9は、この発明の実施の形態3の変形例にかかるカテーテルの貫通穴近傍の構成を示す模式図である。FIG. 9 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to a modification of the third embodiment of the present invention. 図10は、この発明の実施の形態4にかかるカテーテルの概要構成を示す模式図である。FIG. 10 is a schematic view showing a schematic configuration of a catheter according to a fourth embodiment of the present invention. 図11は、この発明の実施の形態5にかかるカテーテルの概要構成を示す模式図である。FIG. 11 is a schematic view showing a schematic configuration of a catheter according to a fifth embodiment of the present invention. 図12は、この発明の実施の形態6にかかるカテーテルの概要構成を示す模式図である。FIG. 12 is a schematic view showing a schematic configuration of a catheter according to Embodiment 6 of the present invention. 図13は、この発明の実施の形態6の変形例1にかかるカテーテルの概要構成を示す模式図である。FIG. 13 is a schematic view showing a schematic configuration of a catheter according to Modification 1 of Embodiment 6 of the present invention. 図14は、この発明の実施の形態6の変形例2にかかるカテーテルの貫通穴近傍の構成を示す模式図である。FIG. 14 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to the second modification of the sixth embodiment of the present invention. 図15は、この発明の実施の形態6の変形例3にかかるカテーテルの貫通穴近傍の構成を示す模式図である。FIG. 15 is a schematic view showing the configuration in the vicinity of the through hole of the catheter according to the third modification of the sixth embodiment of the present invention.
 以下、図面を参照して、この発明を実施するための形態であるカテーテルおよびこれを用いた薬剤投与装置について説明する。 Hereinafter, a catheter as a mode for carrying out the present invention and a drug administration device using the same will be described with reference to the drawings.
(実施の形態1)
 図1は、この発明の実施の形態1にかかるカテーテルの概要構成を示す模式図である。図1に示すように、カテーテル1は、内部チャネル3を有する細長い管状の躯体2をなし、側面に内部チャネル3と外部とを連通する複数の貫通穴4を有している。カテーテル1全体は、生体適合性のある材料、例えば、ポリウレタン、弾性シリコン、テフロン(登録商標)、ポリ塩化ビニル、ポリエチレンなどで形成されている。
Embodiment 1
FIG. 1 is a schematic view showing a schematic configuration of a catheter according to Embodiment 1 of the present invention. As shown in FIG. 1, the catheter 1 is an elongated tubular housing 2 having an internal channel 3 and has a plurality of through holes 4 communicating the internal channel 3 with the outside on the side. The entire catheter 1 is made of a biocompatible material such as polyurethane, elastic silicone, Teflon (registered trademark), polyvinyl chloride, polyethylene and the like.
 このカテーテル1は、管状の躯体2の一端が、内部チャネル3に薬剤を取り入れ、内部チャネル3と連通した開口部である第1の薬剤取入口5と、管状の躯体2の他端が、内部チャネル3に薬剤を取り入れ、内部チャネル3と連通した開口部である第2の薬剤取入口6を有する。また、複数の貫通穴4は、全て管状の躯体2の側面において、第1の薬剤取入口5と第2の薬剤取入口6との間に位置している。 In this catheter 1, one end of a tubular housing 2 introduces a drug into the internal channel 3 and a first drug intake port 5 which is an opening communicating with the internal channel 3 and the other end of the tubular housing 2 A drug is introduced into the channel 3 and has a second drug inlet 6 which is an opening communicating with the internal channel 3. Also, the plurality of through holes 4 are located between the first drug inlet 5 and the second drug inlet 6 on the side surface of the tubular housing 2.
 ここで、第1の薬剤取入口5と第2の薬剤取入口との二つの開口から、内部チャネル3の内部、すなわち複数の貫通穴4側に向けて薬剤が送出されると、カテーテル1の両端から取り入れられた薬剤が各々逆方向に内部チャネル3を流れていき、結局、薬剤は二つの開口の間にある複数の貫通穴4から体内に吐出される。 Here, when the drug is delivered from the two openings of the first drug inlet 5 and the second drug inlet toward the inside of the inner channel 3, that is, the side of the plurality of through holes 4, Drugs introduced from both ends flow in the internal channel 3 in the opposite direction, and eventually, the drug is discharged into the body from the plurality of through holes 4 between the two openings.
 図2は、図1に示したカテーテルを用いた薬剤投与装置の概要構成を示す模式図である。図2に示すように、カテーテル1は、体表11を経由して体内の腫瘍などの投与目標10に挿入されており、貫通穴4が投与目標10内に配置される。 FIG. 2 is a schematic view showing a schematic configuration of a drug administration device using the catheter shown in FIG. As shown in FIG. 2, the catheter 1 is inserted into the administration target 10 such as a tumor in the body via the body surface 11, and the through hole 4 is disposed in the administration target 10.
 そして、カテーテル1の第1の薬剤取入口5には、第1の薬剤送出源であるポンプ7が接続されて連通しており、第2の薬剤取入口6には、第2の薬剤送出源であるポンプ8が接続されて連通している。図2では、カテーテル1にポンプ7およびポンプ8がそれぞれ直接接続されているが、他の部材を経由して間接的に接続および連通してもよい。また、ポンプ7,8は、体表11に取り付けられているが、これに限らず、体内に埋め込まれていてもよいし、体外に離間して設けられていてもよい。 A pump 7 as a first drug delivery source is connected to and in communication with the first drug inlet 5 of the catheter 1, and a second drug delivery source is connected to the second drug inlet 6. The pump 8 is connected and in communication. Although the pump 7 and the pump 8 are directly connected to the catheter 1 in FIG. 2 respectively, they may be connected and communicated indirectly via other members. Moreover, although the pumps 7 and 8 are attached to the body surface 11, it may be not only this but may be embedded in the body, and may be spaced apart and provided outside the body.
 ここで、カテーテル1とポンプ7,8とを用いた場合における各貫通穴4からの薬剤吐出量分布について説明する。なお、複数の貫通穴4は、図1に示すように、第1の薬剤取入口5側から、軸方向に同一径の貫通穴4a,4b,4c,4dが順次配置されているものとして説明する。 Here, the drug discharge amount distribution from each through hole 4 when using the catheter 1 and the pumps 7 and 8 will be described. Note that, as shown in FIG. 1, the plurality of through holes 4 are described as sequentially arranged through holes 4a, 4b, 4c, 4d of the same diameter in the axial direction from the first medicine intake 5 side. Do.
 まず、図3は、ポンプ7のみを用いた場合における貫通穴4a~4dの吐出量分布を示す図である。この場合、貫通穴4a→4b→4c→4dの順で、順次吐出量が減少している。これは、ポンプ7から離隔するにしたがって、順次貫通穴から薬剤が吐出される減圧効果で、徐々に吐出圧が減少し、その結果、吐出量が減少しているものである。 First, FIG. 3 is a diagram showing the discharge amount distribution of the through holes 4a to 4d when only the pump 7 is used. In this case, the discharge amount is successively reduced in the order of the through holes 4 a → 4 b → 4 c → 4 d. This is a pressure reducing effect in which the drug is sequentially discharged from the through holes as it is separated from the pump 7, and the discharge pressure is gradually reduced, and as a result, the discharge amount is reduced.
 同様に、図4は、ポンプ8のみを用いた場合における貫通穴4a~4dの吐出量分布を示す図である。この場合、貫通穴4d→4c→4b→4aの順で、順次吐出量が減少している。これは、ポンプ8から離隔するにしたがって、順次貫通穴から薬剤が吐出される減圧効果で、徐々に吐出圧が減少し、その結果、吐出量が減少しているものである。 Similarly, FIG. 4 is a view showing the discharge amount distribution of the through holes 4a to 4d when only the pump 8 is used. In this case, the discharge amount is successively reduced in the order of the through holes 4 d → 4 c → 4 b → 4 a. This is a pressure reducing effect in which the drug is sequentially discharged from the through holes as it is separated from the pump 8, and the discharge pressure gradually decreases, and as a result, the discharge amount decreases.
 これに対し、図5は、ポンプ7,8によって第1の薬剤取入口5および第2の薬剤取入口6の両端側から薬剤を吐出した場合の貫通穴4a~4dの吐出量分布を示した図である。この場合、図3および図4に示した吐出量分布を合成した吐出量分布となり、貫通穴4a~4dの位置による減圧効果の影響が少なくなり、ほぼ均一な吐出量分布が得られている。すなわち、図2に示すように、カテーテル1の両端側から薬剤を送出し、側面の複数の貫通穴4から吐出させることで、各貫通穴4(4a~4d)の吐出量は、ほぼ一定にすることができる。また、減圧効果の影響が少なくなることから、貫通穴4を設ける軸方向の領域を広くすることができる。なお、この吐出量分布の均一化および吐出領域の広域化の効果は、貫通穴4が複数設けた場合に得られるものである。 On the other hand, FIG. 5 shows the discharge amount distribution of the through holes 4a to 4d when the medicine is discharged from both ends of the first medicine intake 5 and the second medicine intake 6 by the pumps 7, 8 FIG. In this case, the discharge amount distribution obtained by combining the discharge amount distributions shown in FIGS. 3 and 4 is obtained, the influence of the pressure reduction effect due to the positions of the through holes 4a to 4d is reduced, and a substantially uniform discharge amount distribution is obtained. That is, as shown in FIG. 2, the amount of discharge of each through hole 4 (4a to 4d) is made almost constant by delivering the medicine from both ends of the catheter 1 and discharging it from the plurality of through holes 4 on the side. can do. In addition, since the influence of the pressure reduction effect is reduced, the axial region in which the through hole 4 is provided can be widened. The effects of making the discharge amount distribution uniform and widening the discharge area are obtained when a plurality of through holes 4 are provided.
(実施の形態2)
 つぎに、この発明の実施の形態2について説明する。上述した実施の形態1では、管状の躯体2が直線状であったが、この実施の形態2では、図6に示すように、カテーテル1の細長い管状の躯体2の途中に、U字型に折れ曲がった屈曲部12を設けている。そして、複数の貫通穴4は、屈曲部12の片方の側面に設けている。この実施の形態2では、屈曲部12を投与目標10に挿入するようにすれば、カテーテル1の投与目標10への挿入が一方向からで済むため、手技を簡易化することができる。
Second Embodiment
Next, a second embodiment of the present invention will be described. In the first embodiment described above, the tubular casing 2 is straight, but in the second embodiment, as shown in FIG. 6, the tubular casing 2 is U-shaped in the middle of the elongated tubular casing 2 of the catheter 1. A bent portion 12 is provided. The plurality of through holes 4 are provided on one side surface of the bending portion 12. In the second embodiment, when the bending portion 12 is inserted into the administration target 10, the insertion of the catheter 1 into the administration target 10 can be performed from one direction, so that the procedure can be simplified.
 なお、図7に示すように、屈曲部12の他方の側面にさらに貫通穴4′を設け、屈曲部12の側面の両側から薬剤を吐出できるようにしてもよい。 As shown in FIG. 7, a through hole 4 ′ may be further provided on the other side surface of the bending portion 12 so that the medicine can be discharged from both sides of the side surface of the bending portion 12.
(実施の形態3)
 つぎに、この発明の実施の形態3について説明する。この実施の形態3では、図8に示すように、屈曲部12を有する実施の形態2のカテーテルの両端部に、さらに分岐器13を設けている。この分岐器13は、薬剤の送出源からの一つの流路14を、第1の薬剤取入口5と第2の薬剤取入口6とに向けて分岐させるものである。これにより、薬剤送出源としてのポンプが一つで足りることになる。なお、分岐器13には、さらに流量の調整機能等を付加した構成であってもよい。
Third Embodiment
Next, a third embodiment of the present invention will be described. In the third embodiment, as shown in FIG. 8, branching devices 13 are further provided at both ends of the catheter of the second embodiment having the bending portion 12. The branching device 13 branches one flow path 14 from the drug delivery source toward the first drug inlet 5 and the second drug inlet 6. This makes it possible to use one pump as a drug delivery source. The branching unit 13 may further have a flow rate adjustment function or the like.
 なお、図7と同様に、屈曲部12の他方の側面にさらに貫通穴を設け、屈曲部12の側面の両側から薬剤を吐出できるようにしてもよい(図9参照)。 As in FIG. 7, through holes may be further provided in the other side surface of the bending portion 12 so that the medicine can be discharged from both sides of the side surface of the bending portion 12 (see FIG. 9).
(実施の形態4)
 つぎに、この発明の実施の形態4について説明する。上述した実施の形態3では、屈曲部12を有するカテーテルであることを前提としていたが、この実施の形態4では、図10に示すように、図1に示した屈曲部12をもたないカテーテル1の両端、すなわち第1の薬剤取入口5と第2の薬剤取入口6とを接続するとともに、一つのポンプが接続される流路14とを接続する分岐器13aを設けている。すなわち、分岐部13aは、流路14を介して流入した薬剤を、分岐してそれぞれ第1の薬剤取入口5および第2の薬剤取入口6から貫通穴4に向けて送出するようにしている。この場合も、一つのポンプのみを用いるという簡易な構成で実施の形態1と同様な作用効果を得ることができる。
Embodiment 4
Next, the fourth embodiment of the present invention will be described. In the third embodiment described above, it is assumed that the catheter has the bending portion 12. However, in the fourth embodiment, as shown in FIG. 10, the catheter having no bending portion 12 shown in FIG. A branching device 13a is provided, which connects both ends of one, that is, the first drug inlet 5 and the second drug inlet 6, and also connects the flow path 14 to which one pump is connected. That is, the branch portion 13 a branches the medicine flowing in through the flow path 14 and delivers the medicine from the first medicine intake 5 and the second medicine intake 6 toward the through hole 4. . Also in this case, the same function and effect as the first embodiment can be obtained with a simple configuration in which only one pump is used.
(実施の形態5)
 つぎに、この発明の実施の形態5について説明する。この実施の形態5では、図11に示すように、カテーテル1の躯体2を、複数の貫通穴4が位置する薬剤吐出部20と、薬剤吐出部20の内部に挿入可能であり、貫通穴が無い二つの導管部21,22とに分離して構成している。導管部21,22の薬剤吐出部20に対する位置は、軸方向に調整可能である。すなわち、導管部21,22を薬剤吐出部20に対して適切な位置に移動した後、接着剤等で位置固定することによって、所望のカテーテルを得るようにしている。
Fifth Embodiment
A fifth embodiment of the present invention will next be described. In the fifth embodiment, as shown in FIG. 11, the casing 2 of the catheter 1 can be inserted into the medicine ejection portion 20 where the plurality of through holes 4 are located and the medicine ejection portion 20, and the through holes The two non-conduit portions 21 and 22 are separately configured. The positions of the conduits 21 and 22 with respect to the medicine ejection unit 20 can be adjusted in the axial direction. That is, after the conduits 21 and 22 are moved to appropriate positions with respect to the medicine ejection unit 20, the desired catheter is obtained by fixing the position with an adhesive or the like.
 このように構成することにより、複数の貫通穴4のうち、導管部21,22で覆われない貫通穴31からのみ薬剤が吐出され、導管部21,22で覆われた貫通穴30からは薬剤が吐出されない。従って、導管部21,22の薬剤吐出部20に対する位置を適切に調整することで、使用する貫通穴を状況に応じて限定できる。これにより、投与目標10の大きさ等の状況に応じて、適切な薬剤投与部位を精密に選択設定することができる。 By this configuration, the medicine is discharged only from the through hole 31 not covered by the conduits 21 and 22 among the plurality of through holes 4, and the medicine from the through holes 30 covered by the conduits 21 and 22 is medicine Is not discharged. Therefore, by appropriately adjusting the positions of the conduits 21 and 22 with respect to the medicine ejection unit 20, it is possible to limit the through holes to be used depending on the situation. Thereby, according to the conditions, such as the magnitude | size of the administration target 10, an appropriate drug administration site | part can be selected and set precisely.
(実施の形態6)
 つぎに、この発明の実施の形態6について説明する。この実施の形態6のカテーテル41は、図12に示すように、内部チャネル3に対応する内部チャネル43が、第1の薬剤取入口45と連通する第1の内部チャネル43aと、第2の薬剤取入口46と連通する第2の内部チャネル43bとを含んでいる。
Sixth Embodiment
A sixth embodiment of the present invention will next be described. In the catheter 41 according to the sixth embodiment, as shown in FIG. 12, a first internal channel 43a in which the internal channel 43 corresponding to the internal channel 3 communicates with the first medicine intake 45, and a second medicine And a second internal channel 43 b in communication with the inlet 46.
 そして、第1の内部チャネル43aと第2の内部チャネル43bとは、例えば隔壁47で分離しているので、薬剤は、二つの内部チャネル43a,43bを跨いで移動できない。複数の貫通穴は、第1の内部チャネル43aと外部とを連通する複数の第1の貫通穴44と、第2の内部チャネル43bと外部とを連通する複数の第2の貫通穴48とに区分される。すなわち、第1の内部チャネル43aを通った薬剤は、複数の第1の貫通穴44から吐出し、第2の内部チャネル43bを通った薬剤は、複数の第2の貫通穴48から吐出する。つまり、内部チャネル43a,43bと貫通穴44,48とのそれぞれの組合せが二つ存在する。 Then, since the first internal channel 43a and the second internal channel 43b are separated by, for example, the partition wall 47, the drug can not move across the two internal channels 43a and 43b. The plurality of through holes are a plurality of first through holes 44 communicating the first inner channel 43 a with the outside, and a plurality of second through holes 48 communicating the second inner channel 43 b with the outside. It is divided. That is, the drug that has passed through the first inner channel 43 a is discharged from the plurality of first through holes 44, and the drug that has passed through the second inner channel 43 b is discharged from the plurality of second through holes 48. That is, there are two combinations of the internal channels 43a and 43b and the through holes 44 and 48, respectively.
 ここで、管状の躯体42の軸方向において、複数の第1の貫通穴44が位置する範囲と、複数の第2の貫通穴48が位置する範囲は、少なくとも一部が重複するようになっている。このため、第1の貫通穴44からの吐出量分布は、図3に示したようなプロフィールとなり、第2の貫通穴48からの吐出量分布は、図4に示したようなプロフィールになるが、この重複範囲においては、第1の貫通穴44と第2の貫通穴48との吐出量の合計が寄与するので、全体としての吐出量分布は、図5に示したようなプロフィールとなり、各貫通穴位置でほぼ均一となる。 Here, in the axial direction of the tubular housing 42, at least a part of the range in which the plurality of first through holes 44 are positioned and the range in which the plurality of second through holes 48 are disposed are overlapped. There is. For this reason, the discharge amount distribution from the first through hole 44 has a profile as shown in FIG. 3, and the discharge amount distribution from the second through hole 48 has a profile as shown in FIG. Since, in this overlapping range, the sum of the discharge amounts of the first through holes 44 and the second through holes 48 contributes, the discharge amount distribution as a whole becomes a profile as shown in FIG. It becomes almost uniform at the through hole position.
(実施の形態6の変形例1)
 つぎに、この発明の実施の形態6の変形例1について説明する。この変形例1は、実施の形態6の構成を、実施の形態2に適用させたものであり、図13に示すように、屈曲部12に対応した屈曲部52を有する。この屈曲部52は、結合部材51によって結合されている。この実施の形態6の変形例1では、実施の形態2と同様に、屈曲部52を投与目標10に挿入するようにすれば、カテーテル41の投与目標10への挿入が一方向からで済むため、手技を簡易化することができる。
(Modification 1 of Embodiment 6)
Next, a first modification of the sixth embodiment of the present invention will be described. This modification 1 applies the configuration of the sixth embodiment to the second embodiment, and has a bending portion 52 corresponding to the bending portion 12 as shown in FIG. The bent portion 52 is coupled by the coupling member 51. In the first modification of the sixth embodiment, as in the second embodiment, when the bending portion 52 is inserted into the administration target 10, insertion of the catheter 41 into the administration target 10 can be performed from one direction. The procedure can be simplified.
(実施の形態6の変形例2)
 つぎに、この発明の実施の形態6の変形例2について説明する。この変形例2は、実施の形態6の構成を、実施の形態3に適用させたものであり、図14に示すように、屈曲部52を有する変形例1のカテーテルの両端部に、さらに分岐器13を設けている。この分岐器13は、薬剤の送出源からの一つの流路14を、第1の薬剤取入口45と第2の薬剤取入口46とに向けて分岐させるものである。これにより、薬剤送出源としてのポンプが一つで足りることになる。
(Modification 2 of Embodiment 6)
Next, a second modification of the sixth embodiment of the present invention will be described. This modification 2 is obtained by applying the configuration of the sixth embodiment to the third embodiment, and as shown in FIG. 14, it branches further to both ends of the catheter of the modification 1 having the bending portion 52. The vessel 13 is provided. The branching device 13 branches one flow path 14 from the drug delivery source toward the first drug inlet 45 and the second drug inlet 46. This makes it possible to use one pump as a drug delivery source.
(実施の形態6の変形例3)
 つぎに、この発明の実施の形態6の変形例3について説明する。この変形例3は、実施の形態6の構成を、実施の形態4に適用させたものであり、図15に示すように、カテーテル41の両端、すなわち第1の薬剤取入口45と第2の薬剤取入口46とを接続するとともに、一つのポンプが接続される流路14とを接続する分岐器13aを設けている。すなわち、分岐部13aは、流路14を介して流入した薬剤を、分岐してそれぞれ第1の薬剤取入口45および第2の薬剤取入口46からそれぞれ貫通穴44,45に向けて送出するようにしている。この場合も、一つのポンプのみを用いるという簡易な構成で実施の形態1と同様な作用効果を得ることができる。
(Modification 3 of Embodiment 6)
Next, a third modification of the sixth embodiment of the present invention will be described. This modification 3 applies the configuration of the sixth embodiment to the fourth embodiment, and as shown in FIG. 15, both ends of the catheter 41, that is, the first drug intake 45 and the second A branching device 13a is provided which connects with the medicine inlet 46 and also connects with the flow path 14 to which one pump is connected. That is, the branch unit 13 a branches the medicine flowing in through the flow path 14 and delivers the medicine from the first medicine intake 45 and the second medicine intake 46 to the through holes 44 and 45 respectively. I have to. Also in this case, the same function and effect as the first embodiment can be obtained with a simple configuration in which only one pump is used.
 1,41 カテーテル
 2,42 管状の躯体
 3,43,43a,43b 内部チャネル
 4,30,31,44,48 貫通穴
 5,45 第1の薬剤取入口
 6,46 第2の薬剤取入口
 7,8 ポンプ
 10 投与目標
 11 体表
 12,52 屈曲部
 13 分岐器
 14 流路
 20 薬剤吐出部
 21,22 導管部
 47 隔壁
 51 結合部材
1, 41 catheters 2, 42 tubular housings 3, 43, 43a, 43b internal channels 4, 30, 31, 44, 48 through holes 5, 45 first drug intake 6, 46 second drug intake 7, Reference Signs List 8 pump 10 administration target 11 body surface 12, 52 bent portion 13 bifurcater 14 flow path 20 drug discharge portion 21, 22 conduit portion 47 partition wall 51 coupling member

Claims (10)

  1.  内部チャネルを有する細長い管状の躯体をしており、
     前記内部チャネルに薬剤を取り入れる第1の薬剤取入口と、
     前記内部チャネルに薬剤を取り入れる第2の薬剤取入口と、
     前記管状の躯体の側面であって前記第1の薬剤取入口と前記第2の薬剤取入口との間に位置し、前記内部チャネルと外部とを連通する複数の貫通穴と、
     を有することを特徴とするカテーテル。
    It has an elongated tubular housing with an internal channel,
    A first drug intake for introducing a drug into the internal channel;
    A second drug inlet for introducing drug into the internal channel;
    A plurality of through holes located between the first drug inlet and the second drug inlet on the side surface of the tubular housing and communicating the internal channel with the outside;
    A catheter characterized by having:
  2.  前記細長い管状の躯体の途中に、U字型に折り曲がった屈曲部を有することを特徴とする請求項1に記載のカテーテル。 The catheter according to claim 1, further comprising a U-shaped bent portion in the middle of the elongated tubular housing.
  3.  薬剤の送出源からの一つの流路を前記第1の薬剤取入口と前記第2の薬剤取入口とに向けて分岐させる分岐器をさらに有することを特徴とする請求項1に記載のカテーテル。 The catheter according to claim 1, further comprising a bifurcating device for branching one flow path from a drug delivery source toward the first drug intake and the second drug intake.
  4.  前記内部チャネルは、前記第1の薬剤取入口に連通する第1の内部チャネルと、前記第2の薬剤取入口に連通する第2の内部チャネルとを含み、
     前記複数の貫通穴は、前記第1の内部チャネルと外部とを連通する複数の第1の貫通穴と、前記第2の内部チャネルと外部とを連通する複数の第2の貫通穴を含み、
     前記第1の内部チャネルと前記第2の内部チャネルとは互いに分離され、
     前記管状の躯体の軸方向において前記複数の第1の貫通穴が位置する範囲と前記複数の第2の貫通穴が位置する範囲とは少なくとも一部が重複することを特徴とする請求項1に記載のカテーテル。
    The inner channel includes a first inner channel in communication with the first drug inlet and a second inner channel in communication with the second drug inlet.
    The plurality of through holes includes a plurality of first through holes communicating the first internal channel with the outside, and a plurality of second through holes communicating the second internal channel with the outside.
    The first internal channel and the second internal channel are separated from one another,
    The range in which the plurality of first through holes are located in the axial direction of the tubular housing and the range in which the plurality of second through holes are located at least partially overlap each other. Description catheter.
  5.  内部チャネルを有する細長い管状の躯体をしており、前記内部チャネルに薬剤を取り入れる第1の薬剤取入口と、前記内部チャネルに薬剤を取り入れる第2の薬剤取入口と、前記管状の躯体の側面であって前記第1の薬剤取入口と前記第2の薬剤取入口との間に位置し前記内部チャネルと外部とを連通する複数の貫通穴と、を有するカテーテルと、
     前記カテーテルの第1の薬剤取入口と第2の薬剤取入口とに、直接または間接に連通する少なくとも一つの薬剤送出源と、
     を有することを特徴とする薬剤投与装置。
    An elongated tubular rod having an inner channel, wherein a first drug inlet for introducing a drug into the inner channel, a second drug inlet for receiving a drug into the inner channel, and a side surface of the tubular rod A catheter having a plurality of through holes located between the first drug intake and the second drug intake and communicating the internal channel with the outside;
    At least one drug delivery source in direct or indirect communication with the first drug inlet and the second drug inlet of the catheter;
    A drug administration device characterized by having.
  6.  前記薬剤送出源は、前記カテーテルの第1の薬剤取入口に直接または間接に連通する第1の薬剤送出源と、前記カテーテルの第2の薬剤取入口に直接または間接に連通する前記第1の薬剤送出源とは別の第2の薬剤送出源とを含むことを特徴とする請求項5に記載の薬剤投与装置。 The drug delivery source may be a first drug delivery source in direct or indirect communication with a first drug intake of the catheter, and the first in direct communication with the second drug intake of the catheter. 6. The drug delivery device according to claim 5, comprising a second drug delivery source separate from the drug delivery source.
  7.  前記カテーテルの細長い管状の躯体の途中に、U字型に折り曲がった屈曲部を有することを特徴とする請求項5に記載の薬剤投与装置。 The drug administration device according to claim 5, further comprising a U-shaped bent portion in the middle of the elongated tubular housing of the catheter.
  8.  前記薬剤送出源は、単一の装置であり、
     前記カテーテルは、前記単一の薬剤送出源からの一つの流路を前記第1の薬剤取入口と前記第2の薬剤取入口とに向けて分岐させる分岐器をさらに有することを特徴とする請求項5に記載の薬剤投与装置。
    The drug delivery source is a single device,
    The catheter is characterized in that it further comprises a bifurcating device for branching one flow path from the single drug delivery source towards the first drug intake and the second drug intake. The drug administration device according to Item 5.
  9.  前記内部チャネルは、前記第1の薬剤取入口に連通する第1の内部チャネルと、前記第2の薬剤取入口に連通する第2の内部チャネルとを含み、
     前記複数の貫通穴は、前記第1の内部チャネルと外部とを連通する複数の第1の貫通穴と、前記第2の内部チャネルと外部とを連通する複数の第2の貫通穴とを含み、
     前記第1の内部チャネルと前記第2の内部チャネルとは互いに分離され、
     前記管状の躯体の軸方向において前記複数の第1の貫通穴が位置する範囲と前記複数の第2の貫通穴が位置する範囲とは少なくとも一部が重複することを特徴とする請求項5に記載の薬剤投与装置。
    The inner channel includes a first inner channel in communication with the first drug inlet and a second inner channel in communication with the second drug inlet.
    The plurality of through holes includes a plurality of first through holes communicating the first internal channel with the outside, and a plurality of second through holes communicating the second internal channel with the outside. ,
    The first internal channel and the second internal channel are separated from one another,
    The area in which the plurality of first through holes are located in the axial direction of the tubular housing and the area in which the plurality of second through holes are located at least partially overlap each other. Drug administration device as described.
  10.  内部チャネルを有する細長い管状の躯体をしており、側面に前記内部チャネルと外部とを連通する複数の貫通穴をもつカテーテルと、
     前記カテーテルの前記内部チャネルに薬剤を送出する少なくとも一つの薬剤送出源と、
     を有し、
     前記薬剤送出源は、前記カテーテルの両端側から各々逆方向に、前記内部チャネルを通って前記複数の貫通穴に向けて薬剤を送出することを特徴とする薬剤投与装置。
    A catheter having an elongated tubular housing having an internal channel, and a plurality of through holes communicating with the external channel from the internal channel on the side surface;
    At least one drug delivery source for delivering a drug to the internal channel of the catheter;
    Have
    The drug delivery device according to claim 1, wherein the drug delivery source delivers the drug toward the plurality of through holes through the internal channel in opposite directions from both ends of the catheter.
PCT/JP2010/057099 2009-04-22 2010-04-21 Catheter and medication administering device WO2010123041A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009-104484 2009-04-22
JP2009104484A JP2010252924A (en) 2009-04-22 2009-04-22 Catheter and medication administering device

Publications (1)

Publication Number Publication Date
WO2010123041A1 true WO2010123041A1 (en) 2010-10-28

Family

ID=43011157

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2010/057099 WO2010123041A1 (en) 2009-04-22 2010-04-21 Catheter and medication administering device

Country Status (2)

Country Link
JP (1) JP2010252924A (en)
WO (1) WO2010123041A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102553012A (en) * 2012-02-09 2012-07-11 杨佐明 Self-control pulse irrigating tube

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378016A (en) * 1981-07-15 1983-03-29 Biotek, Inc. Artificial endocrine gland containing hormone-producing cells
JPH05500620A (en) * 1989-06-21 1993-02-12 ブラウン ユニバーシティ リサーチ ファウンデイション Neurotherapy system
JPH05501968A (en) * 1989-12-08 1993-04-15 バイオシンセシス,インコーポレーテッド Implantable devices for drug or other liquid administration
JPH07500260A (en) * 1991-06-28 1995-01-12 ブラウン ユニバーシティ リサーチ ファウンデーション Replenishable nerve implant device and method
JP2006528906A (en) * 2003-05-12 2006-12-28 アイ−フロー コーポレイション Catheter for uniform drug delivery

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378016A (en) * 1981-07-15 1983-03-29 Biotek, Inc. Artificial endocrine gland containing hormone-producing cells
JPH05500620A (en) * 1989-06-21 1993-02-12 ブラウン ユニバーシティ リサーチ ファウンデイション Neurotherapy system
JPH05501968A (en) * 1989-12-08 1993-04-15 バイオシンセシス,インコーポレーテッド Implantable devices for drug or other liquid administration
JPH07500260A (en) * 1991-06-28 1995-01-12 ブラウン ユニバーシティ リサーチ ファウンデーション Replenishable nerve implant device and method
JP2006528906A (en) * 2003-05-12 2006-12-28 アイ−フロー コーポレイション Catheter for uniform drug delivery

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102553012A (en) * 2012-02-09 2012-07-11 杨佐明 Self-control pulse irrigating tube

Also Published As

Publication number Publication date
JP2010252924A (en) 2010-11-11

Similar Documents

Publication Publication Date Title
US11534592B2 (en) Systems and methods for drug delivery, treatment, and monitoring
CN101400401B (en) A fluid connector for fluid delivery apparatus
CN101400386B (en) Apparatus for fluid delivery with implantable housing openable for providing access to a fluid connector
JP6492093B2 (en) Interventional sinus endoscope
US7766875B2 (en) Catheter for reduced reflux in targeted tissue delivery of a therapeutic agent
CN103889304B (en) At least comprise the multisection type sleeve pipe in a chamber
WO2008030485A3 (en) Catheter for localized drug delivery and/or electrical stimulation
EP1421970A3 (en) Combination thrombolytic infusion catheter and a dilator system
EP3157605B1 (en) Apparatus for selectively delivering particles into the distal portion of the left gastric artery
US10376683B2 (en) Catheter system for delivery of a ureteral catheter
CN106535778A (en) Laparoscopic spray applicator and adapter
WO2010123041A1 (en) Catheter and medication administering device
CN111759477B (en) Pleurodesis device and method
CN201625318U (en) Special developing element and conduit provided with same
JP6544097B2 (en) Drug supply device
CN218046176U (en) Multi-channel joint
GB2422410A (en) A connector for coupling a plurality of intravenous tubes
JP6864840B2 (en) Drug supply equipment
TWI221422B (en) Quasi-T shaped catheter for chemotherapy
CN113230516A (en) Drug infusion system
JP2006192178A (en) T-type conduit for chemotherapy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10767098

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10767098

Country of ref document: EP

Kind code of ref document: A1